Alterations of thrombogenesis, endothelial damage and oxidative stress with reperfusion during femoral artery bypass surgery for peripheral vascular disease

Pathophysiology of Haemostasis and Thrombosis

Volumn 32, Issue 4, 2002, Pages 158-164

  Makin, Andrew J ^a   Chung, Natali A Y ^a   Silverman, Stanley H ^a   Lip, Gregory Y H ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Endothelium; Oxidative stress; Peripheral vascular disease; Thrombogenesis

Indexed keywords

LIPID HYDROPEROXIDE; PADGEM PROTEIN; THROMBOPLASTIN; VON WILLEBRAND FACTOR;

ACUTE DISEASE; ADULT; AGED; ANALYSIS OF VARIANCE; ARTERY CLAMP; ARTICLE; BYPASS SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ELECTIVE SURGERY; ENDOTHELIUM INJURY; FEMALE; FEMORAL ARTERY; FEMORAL ARTERY BYPASS SURGERY; HUMAN; HYPOTHESIS; ISCHEMIA; LEG REVASCULARIZATION; MALE; MEASUREMENT; OPERATION DURATION; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REPERFUSION; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

AGED; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FEMORAL ARTERY; HUMANS; LIPID PEROXIDES; MALE; MIDDLE AGED; OXIDATIVE STRESS; P-SELECTIN; PERIPHERAL VASCULAR DISEASES; REPERFUSION INJURY; THROMBOPLASTIN; THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 0345377854     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070421     Document Type: Article

References (24)

1. Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ: Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384-392.
2. Management of peripheral arterial disease (PAD): TransAtlantic Inter-Society Consensus (TASC). Eur J Vasc Endovasc Surg 2000;19(suppl A):Si-250.
3. de Vries SO, Hunink MG: Results of aortic bifurcation grafts for aortoiliac occlusive disease: A meta-analysis. J Vasc Surg 1997;26:558-569.
4. Smith FB, Lowe GD, Fowkes FG, Rumley A, Rumley AG, Donnan PT, et al: Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis 1993;102:155-162.
5. Blann AD, Farrell A, Picton A, McCollum CN: Relationship between endothelial cell markers and arterial stenosis in peripheral and carotid artery disease. Thromb Res 2000;97:209-216.
6. Philipp CS, Cisar LA, Kim HC, Wilson AC, Saidi P, Kostis JB: Association of hemostatic factors with peripheral vascular disease. Am Heart J 1997;134(5 Pt 1):978-984.
7. Blann AD, Seigneur M, Steiner M, Boisseau MR, McCollum CN: Circulating endothelial cell markers in peripheral vascular disease: Relationship to the location and extent of atherosclerotic disease. Eur J Clin Invest 1997;27:916-921.
8. Blann AD, Amiral J, McCollum CN, Lip GY: Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls. Atherosclerosis 2000;152:29-34.
9. Blann AD, Lip GY: Hypothesis: Is soluble P-selectin a new marker of platelet activation? Atherosclerosis 1997;128:135-138.
10. Blann AD, Lip GY, Beevers DG, McCollum CN: Soluble P-selectin in atherosclerosis: A comparison with endothelial cell and platelet markers. Thromb Haemost 1997;77:1077-1080.
11. Blann A, Morris J, McCollum C: Soluble L-selectin in peripheral arterial disease: Relationship with soluble E-selectin and soluble P-selectin. Atherosclerosis 1996;126:227-231.
12. Blann AD, Dobrotova M, Kubisz P, McCollum CN: von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. Thromb Haemost 1995;74:626-630.
13. Blann AD, Seigneur M, Boisseau MR, Taberner DA, McCollum CN: Soluble P selectin in peripheral vascular disease: Relationship to the location and extent of atherosclerotic disease and its risk factors. Blood Coagul Fibrinolysis 1996;7:789-793.
14. Lau CS, Scott N, Shaw JW, Belch JJ: Increased activity of oxygen free radicals during reperfusion in patients with peripheral arterial disease undergoing percutaneous peripheral artery balloon angioplasty. Int Angiol 1991;10:244-246.
15. Rabl H, Khoschsorur G, Colombo T, Tatzber F, Esterbauer H: Human plasma lipid peroxide levels show a strong transient increase after successful revascularization operations. Free Radic Biol Med 1992;13:281-288.
16. Hafez HM, Berwanger CS, McColl A, Richmond W, Wolfe JH, Mansfield AO, et al: Myocardial injury in major aortic surgery. J Vasc Surg 2000;31:742-750.
17. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Wolff SP: Measurement of plasma hydroperoxide concentrations by the ferrous-oxidation-xylenol orange assay in conjunction with triphenylphosphine. Anal Biochem 1994;220:403-409.
18. Stohlawetz P, Hergovich N, Stiegler G, Eichler HG, Hocker P, Kapiotis S, Jilma B: Differential induction of P-selectin expression on platelets by two cell separators during platelet-pheresis and the effect of gender on the release of soluble P-selectin. Transfusion 1998;38:24-30.
19. Pernerstorfer T, Stohlawetz P, Kapiotis S, Eichler HG, Jilma B: Partial inhibition of nitric oxide synthase primers the stimulated pathway of vWF-secretion in man. Atherosclerosis 2000;148:43-47.
20. Roux S, Qiu C, Sprecher U, Osterwalder R, Clozel JP: Protective effects of endothelin receptor antagonists in dogs with aortic cross-clamping. J Cardiovasc Pharmacol 1999;34:199-205.
21. Yokoyama K, Kimura M, Nakamura K, Nakamura K, Itoman M: Time course of postischemic superoxide generation in venous effluent from reperfused rabbit hindlimbs. J Reconstr Microsurg 1999;15:215-221.
22. Kahraman S, Kilinc K, Dal D, Erdem K: Propofol attenuates formation of lipid peroxides in tourniquet-induced ischaemia-reperfusion injury. Br J Anaesth 1997;78:279-281.
23. Wilcox JN, Smith KM, Schwartz SM, Gordon D: Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1989;86:2839-2843.
24. Thiruvikraman SV, Guha A, Roboz J, Taubman MB, Nemerson Y, Fallon JT: In situ localization of tissue factor in human atherosclerotic plaques by binding of digoxigenin-labeled factors VIIa and X. Lab Invest 1996;75:451-461.